Mindfulness in ovarian cancer

A six-week programme of group mindfulness sessions to improve mental health and wellbeing in patients with recurrent ovarian cancer: a feasibility study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN95243663

Enrollment

Registered

2016-12-05

Start date

2016-11-09

Completion date

Unknown

Last updated

2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Cancer, Primary sub-specialty: Gynaecological Cancers

Interventions

All participants receive a 6-week mindfulness-based intervention comprising a total of 8.5 contact hours. The intervention has been specifically adapted and modified for cancer patients based around

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Any confirmed recurrence of OvCa at any stage 2. Aged 18 years and above 3. Willing to participate and provide informed consent 4. Fluent English (questionnaires validated and interviews conducted in English);Inclusion criteria: 1. Any confirmed recurrence of OvCa at any stage 2. Aged 18 years and above 3. Willing to participate and provide informed consent 4. Fluent English (questionnaires validated and interviews conducted in English)

Exclusion criteria

Exclusion criteria: 1. Additional cancer diagnoses 2. Any significant mental illness (i.e. overt psychosis, history of suicidal ideation) but not to include clinical depression and/or anxiety 3. Receiving any other psychological therapy;Exclusion criteria: 1. Additional cancer diagnoses 2. Any significant mental illness (i.e. overt psychosis, history of suicidal ideation) but not to include clinical depression and/or anxiety 3. Receiving any other psychological therapy

Design outcomes

Primary

Measure	Time frame
Feasibility outcomes: 1. Recruitment rate 2. Response rates 3. Number of patients completing the intervention 4. Number of patients completing the 6 month follow-up 5. Qualitative assessment of the intervention 6. Quantitative data analysis;Feasibility outcomes: 1. Recruitment rate 2. Response rates 3. Number of patients completing the intervention 4. Number of patients completing the 6 month follow-up 5. Qualitative assessment of the intervention 6. Quantitative data analysis	—

Measure

Time frame

Feasibility outcomes: 1. Recruitment rate 2. Response rates 3. Number of patients completing the intervention 4. Number of patients completing the 6 month follow-up 5. Qualitative assessment of the intervention 6. Quantitative data analysis;Feasibility outcomes: 1. Recruitment rate 2. Response rates 3. Number of patients completing the intervention 4. Number of patients completing the 6 month follow-up 5. Qualitative assessment of the intervention 6. Quantitative data analysis

—

Secondary

Measure	Time frame
1. Anxiety 2. Depression 3. Quality of life 4. Diurnal cortisol variations;1. Anxiety 2. Depression 3. Quality of life 4. Diurnal cortisol variations	—

Countries

United Kingdom

Contacts

Public Contact; ;

;

;;

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026